Skip to content
BlockInterop

Clinical Research

Connecting Clinical Trials With Real-World Healthcare Data

How standards-based data workflows change trial matching, pre-screening, and study startup timelines.

The short answer

Recruitment, not science, is what most often stalls a trial, and recruitment is a data access problem. Standards-based connectivity between EHRs and research operations, using FHIR queries, consent-aware workflows, and reliable patient matching, lets sites pre-screen against real clinical data instead of manual chart review, which is where the largest time savings in study startup are available.

Recruitment is a data access problem

Published analyses of trial performance keep landing in the same place: enrollment, not efficacy, is the most common reason studies fail or terminate. A 2020 review in Perspectives in Clinical Research reported that 55% of terminated trials ended because of low accrual, that average enrollment efficiency is under 40% for Phase III and IV studies, and that more than 80% of trials globally fail to enroll on time.

The same review noted that more than 40% of trials amend the protocol before the first subject visit, which is often a signal that eligibility criteria were written without visibility into how the target population actually appears in clinical data.

What standards-based connectivity changes

When research operations can query structured clinical data through FHIR rather than waiting on extracts or manual review, three things change: feasibility assessment becomes evidence-based, pre-screening can run continuously instead of in bursts, and site burden drops because coordinators review a filtered list rather than a chart pile.

  • Feasibility: test eligibility criteria against real population counts before the protocol is locked.
  • Pre-screening: automate the mechanical portion of eligibility, leaving clinical judgment to coordinators.
  • Consent: capture and honor consent state as data, with an auditable trail.
  • Matching: resolve identity across EHR, registry, and study systems so candidates are not duplicated or missed.
  • Site enablement: give each site a repeatable technical playbook instead of a bespoke build.

Governance is the gating factor

Research access to clinical data carries obligations that operational integration does not: IRB oversight, minimum necessary use, de-identification where appropriate, participant consent scope, and clear separation between care and research use. Building these rules into the data flow, rather than layering them on as manual review, is what makes a connected recruitment workflow sustainable across studies.

A practical first step

Pick one study and one site, define the eligibility criteria that can be evaluated from structured data, connect that narrow query path end to end with consent handling and audit in place, and measure the coordinator time it displaces. That single proven path is a far better basis for a research connectivity program than a platform selection made before any data has moved.

How BlockInterop supports this work

Sources

Every figure cited in this article links to its public source. BlockInterop publishes no client names, outcomes, or internal performance statistics.

  1. 1.Perspectives in Clinical Research (2020), Recruitment and retention of participants in clinical studies
  2. 2.Contemporary Clinical Trials Communications (2018), Factors associated with clinical trials that fail

Answers

Questions This Article Answers

Direct answers, written to stand on their own.

Why do clinical trials miss enrollment targets?

Published research points to recruitment mechanics rather than science. A 2020 review in Perspectives in Clinical Research reported that 55% of terminated trials ended due to low accrual, that enrollment efficiency averages under 40% in Phase III and IV trials, and that more than 80% of trials globally fail to enroll on time.

How does FHIR help trial recruitment?

FHIR gives research systems a standard way to query structured clinical data such as conditions, medications, labs, and encounters. That supports evidence-based feasibility assessment before a protocol is locked and continuous automated pre-screening afterward, so coordinators spend their time on clinical judgment rather than chart review.

What has to be in place before connecting EHR data to research workflows?

IRB-approved use, a defined consent scope captured as data, minimum-necessary data scoping with de-identification where appropriate, reliable patient matching across systems, and an audit trail. These governance elements should be built into the data flow rather than handled as manual review.

Keep reading

More Insights

Nationwide Exchange

Preparing Your Organization for TEFCA and QHIN Participation

What technical, legal, and operational readiness actually looks like before you choose a participation model.

Read Preparing Your Organization for TEFCA and QHIN Participation
Regulatory

Turning CMS Interoperability Requirements Into an Implementation Roadmap

A sequencing approach that connects regulatory milestones to architecture decisions and delivery capacity.

Read Turning CMS Interoperability Requirements Into an Implementation Roadmap
Standards

FHIR vs. HL7: Choosing the Right Approach for Your Workflow

Both standards have a place. The decision depends on workflow, latency, partner capability, and operational ownership.

Read FHIR vs. HL7: Choosing the Right Approach for Your Workflow

Not Sure Where to Start?

Schedule a focused conversation to identify your interoperability priorities, risks, dependencies, and most practical next steps.

Talk With an Interoperability Expert

Ready to Move Interoperability Forward?

Whether you are preparing for new CMS requirements, modernizing healthcare integrations, connecting to a QHIN, or building a FHIR-enabled product, BlockInterop can help you define the right path and execute it.

Tell us about your organization, current challenge, timeline, and desired outcome.